LPS was shown to be a causal factor for hypercoagulability in T2D [29]; thus, LPS-induced thrombotic propensity and amyloid fibril formation were reversed in vitro by adding LBP to the plasma of T2D individuals [29]. This evidence concerns the gene LBP and type 2 diabetes mellitus.